Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 4

1.

Phase I trial of escalating doses of paclitaxel combined with fixed doses of cisplatin and doxorubicin in advanced endometrial cancer and other gynecologic malignancies: a Gynecologic Oncology Group study.

Fleming GF, Fowler JM, Waggoner SE, Copeland LJ, Greer BE, Horowitz I, Sutton G, Schilder RJ, Fracasso PM, Ball HG, McGuire WP 3rd.

J Clin Oncol. 2001 Feb 15;19(4):1021-9.

PMID:
11181665
2.

The platinum compounds and paclitaxel in the management of carcinomas of the endometrium and uterine cervix.

Thigpen T, Vance RB, Khansur T.

Semin Oncol. 1995 Oct;22(5 Suppl 12):67-75. Review.

PMID:
7481864
3.

New aspects of adjuvant therapy in endometrial cancer: current standards and future directions.

Sehouli J, Koensgen D, Oskay-Ozcelik G, Mustea A.

Crit Rev Oncol Hematol. 2008 Sep;67(3):204-12. doi: 10.1016/j.critrevonc.2008.02.011. Epub 2008 Apr 14. Review.

PMID:
18407513
4.

The role of ifosfamide in gynecologic cancer.

Thigpen T, Lambuth BW, Vance RB.

Semin Oncol. 1992 Feb;19(1 Suppl 1):30-4. Review.

PMID:
1411619

Supplemental Content

Support Center